Thrombotic occlusion of a drug-eluting stent: Is IVUS mandatory

Journal of Invasive Cardiology

Volumn 18, Issue 9, 2006, Pages

  Arnold, Jayanth R ^a   Van Gaal, William J ^a   Banning, Adrian P ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB;

ACUTE CORONARY SYNDROME; AGED; ANAMNESIS; ARTICLE; BALLOON DILATATION; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DISEASE COURSE; DRUG ELUTING STENT; HOSPITAL ADMISSION; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PATIENT MONITORING; THERAPY EFFECT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; CORONARY THROMBOSIS; DRUG DELIVERY SYSTEMS; HUMANS; MALE; STENTS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33748754093     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hill RA, Dundar Y, Bakhai A, et al. Drug-eluting stents: An early systematic review to inform policy. Eur Heart J 2004;25:902-919.
2. Orford JL, Lennon R, Melby S, et al. Frequency and correlates of coronary stent thrombosis in the modern era: Analysis of a single center registry. J Am Coll Cardiol 2002;40:1567-1572.
3. Cutlip DE, Baim DS, Ho KK, et al. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001;103:1967-1971.
4. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.
5. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuat ion of ant iplatelet therapy. Lancet 2004;364:1519-1521.
6. Bavry AA, Kumbhani DJ, Helton TJ, et al. Risk of thrombosis with the use of sirolimus eluting stents for percutaneous coronary intervention (from registry and clinical trial data). Am J Cardiol 2005;95:1469-1472.
7. Bavry AA, Kumbhani DJ, Helton TJ, et al. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: A meta-analysis. J Am Coll Cardiol 2005;45:941-946.
8. Moreno R, Fernandez C, Hernandez R, et al. Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005;45:954-959.
9. Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus eluting stent implantation. Circulation 2004;109:1930-1932.
10. Alfonso F, Suarez A, Angiolillo DJ, et al. Findings of intravascular ultrasound during acute stent thrombosis. Heart 2004;90:1455-1459.
11. Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study. J Am Coll Cardiol 2005;45:995-998.
12. Fujii K, Mintz GS, Kobayashi Y, et al. Contribution of stent underexpansion to recurren ce after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004;109:1085-1088.
13. Uren NG, Schwarzacher SP, Metz JA, et al. Predictors and outcomes of stent thrombosis: An intravascular ultrasound registry. Eur Heart J 2002;23:124-132.
14. Blackman DJ, Porto I, Shirodaria C, et al. Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis. Am J Cardiol 2004;94:922-925.